Additionally, it addresses the FDA’s communications With all the applicant, the retention of records that aid the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer ownership of the SE report to a fresh applicant and electronic submission with the SE report and amendmen